礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LLY 礼来

未开盘 09-19 16:00:00 EDT

915.04

+10.07

+1.11%

盘后911.00

-4.04-0.44%

19:59 EDT

最高916.81	最低903.86	成交量244.65万
今开912.85	昨收904.97	日振幅1.43%
总市值8,697亿	流通市值8,675亿	总股本9.50亿
成交额22.28亿	换手率0.26%	流通股本9.48亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LLY","market":"US","secType":"STK","nameCN":"礼来","latestPrice":915.04,"timestamp":1726776000000,"preClose":904.97,"halted":0,"volume":2446486,"hourTrading":{"tag":"盘后","latestPrice":911,"preClose":915.04,"latestTime":"19:59 EDT","volume":279145,"amount":255416556.44925,"timestamp":1726790382995},"delay":0,"floatShares":948000000,"shares":950425778,"eps":8.121151,"marketStatus":"未开盘","marketStatusCode":0,"change":10.07,"latestTime":"09-19 16:00:00 EDT","open":912.85,"high":916.81,"low":903.86,"amount":2228375412.2364,"amplitude":0.01431,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.121151,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1726819200000},"adr":0,"listingDate":102488400000,"adjPreClose":904.97,"adrRate":0,"dividendRate":0.005311,"preHourTrading":{"tag":"盘前","latestPrice":912,"preClose":904.97,"latestTime":"09:29 EDT","volume":11568,"amount":10580803.075199999,"timestamp":1726752591067},"postHourTrading":{"tag":"盘后","latestPrice":911,"preClose":915.04,"latestTime":"19:59 EDT","volume":279145,"amount":255416556.44925,"timestamp":1726790382995},"volumeRatio":1.182742,"impliedVol":0.2982,"impliedVolPercentile":0.3294},"requestUrl":"/m/hq/s/LLY","defaultTab":"news","newsList":[{"id":"2468661875","title":"礼来(LLY.US)希望仿制药使用者提供医疗记录 欲向”仿制版减肥药“开战?","url":"https://stock-news.laohu8.com/highlight/detail?id=2468661875","media":"智通财经","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468661875?lang=zh_cn&edition=full","pubTime":"2024-09-20 12:05","pubTimestamp":1726805156,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国医药巨头礼来公司近日要求服用其畅销减肥药仿制版本的使用者们出于安全原因向公司提供其医疗记录，此举可能是为了打击销售仿制版减肥复方药物的企业或者药房。礼来公司的一位发言人证实了这封信的真实性，并表示这是该公司持续监控市场和评估其药品安全性的努力的一部分。这封信是品牌药品制造商与制造和销售仿制版本的药物公司之间斗争加剧的最新迹象。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1185054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0009355771.USD","LU0289739699.SGD","LU0882574139.USD","BK4534","LU0097036916.USD","IE0004445239.USD","LLY","LU0106261372.USD","LU1280957306.USD","LU0354030511.USD","BK4585","IE00BJJMRZ35.SGD","LU0256863902.USD","LU1061106388.HKD","LU1551013342.USD","LU0689472784.USD","LU0079474960.USD","LU0114720955.EUR","LU1057294990.SGD","BK4588","IE00B2B36J28.USD","LU0882574055.USD","IE00BK4W5M84.HKD","LU1267930730.SGD","LU0820561818.USD","LU0820561909.HKD","IE0002141913.USD","LU0198837287.USD","LU1064131342.USD","LU0061475181.USD","BK4007","LU0823416689.USD","BK4516","LU0640476718.USD","LU1069344957.HKD","159891","LU0006306889.USD","LU0094547139.USD","LU0471298694.HKD","LU0471298777.SGD","GB00BDT5M118.USD","IE00BFTCPJ56.SGD","IE00BJLML261.HKD","IE00B1BXHZ80.USD","LU0238689110.USD","LU0672654240.SGD","LU0122379950.USD","LU0096364046.USD","LU0354030438.USD","IE00BJT1NW94.SGD"],"gpt_icon":1},{"id":"2468682377","title":"礼来上涨1.27%，报916.481美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2468682377","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468682377?lang=zh_cn&edition=full","pubTime":"2024-09-20 03:45","pubTimestamp":1726775155,"startTime":"0","endTime":"0","summary":"9月20日，礼来(LLY)盘中上涨1.27%，截至03:45，报916.481美元/股，成交14.22亿美元。财务数据显示，截至2024年06月30日，礼来收入总额200.71亿美元，同比增长31.42%；归母净利润52.1亿美元，同比增长67.62%。大事提醒：9月16日，礼来获Cantor Fitzgerald重申评级Overweight，目标价885美元。11月7日，礼来将披露2024财年三季报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/09/20034543367287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4007","LU0006306889.USD","LU0354030511.USD","LU0640476718.USD","BK4588","LU1267930730.SGD","IE00BJT1NW94.SGD","LU0672654240.SGD","LU0114720955.EUR","LU0471298777.SGD","LU1023059063.AUD","LU0689472784.USD","LLY","LU0882574139.USD","LU0417517546.SGD","LU0320765059.SGD","LU1551013342.USD","LU0820561818.USD","IE0002141913.USD","LU0823416689.USD","LU1057294990.SGD","BK4534","LU0061475181.USD","LU0943347566.SGD","LU0289739699.SGD","BK4516","LU0354030438.USD","LU0122379950.USD","LU0471298694.HKD","IE00BFTCPJ56.SGD","IE00B1BXHZ80.USD","LU0882574055.USD","LU1069344957.HKD","LU0466842654.USD","LU1064131342.USD","BK4533","LU0096364046.USD","GB00BDT5M118.USD","BK4581","LU1061106388.HKD","LU1280957306.USD","IE0009355771.USD","LU0198837287.USD","LU0256863902.USD","IE0004445239.USD","IE00BK4W5L77.USD","IE00B2B36J28.USD","IE00BJLML261.HKD","IE00B4R5TH58.HKD","LU0079474960.USD"],"gpt_icon":0},{"id":"2468652070","title":"更新版 1-美国 FDA 拒绝批准旺达的胃麻痹药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2468652070","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468652070?lang=zh_cn&edition=full","pubTime":"2024-09-19 19:29","pubTimestamp":1726745379,"startTime":"0","endTime":"0","summary":"     路透9月19日 - 美国食品和药物管理局拒绝批准万达制药公司  治疗胃麻痹症状的药物。该公司股价在盘前交易中下跌约14%，至4.26美元。万达正在寻求卫生监管机构批准该公司的药物tradipitant用于治疗胃瘫，胃瘫是一种以胃排空延迟为特征的疾病。万达公司从礼来  公司获得了替替匹坦的授权，目前也在研究它对晕车症的治疗作用。卫生监管机构对替替匹坦实施了部分临床搁置，禁止进行超过12周的试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU0289739699.SGD","LU0708995401.HKD","LU0097036916.USD","IE0004445239.USD","LLY","LU0106261372.USD","LU0320765059.SGD","LU0354030511.USD","LU1280957306.USD","BK4585","IE00BJJMRZ35.SGD","LU0256863811.USD","LU1061106388.HKD","LU0689472784.USD","LU0079474960.USD","LU0114720955.EUR","BK4588","IE00B2B36J28.USD","LU0882574055.USD","IE00BK4W5M84.HKD","LU1267930730.SGD","LU1023059063.AUD","LU0820561818.USD","LU0820561909.HKD","IE0002141913.USD","IE00B4R5TH58.HKD","LU1064131342.USD","LU0061475181.USD","BK4007","LU0823416689.USD","BK4516","BK4533","LU0417517546.SGD","LU0943347566.SGD","VNDA","LU0006306889.USD","LU0094547139.USD","LU0471298694.HKD","LU0471298777.SGD","GB00BDT5M118.USD","IE00BFTCPJ56.SGD","IE00B1BXHZ80.USD","LU0238689110.USD","LU0466842654.USD","LU0672654240.SGD","LU0122379950.USD","BK4139","LU0354030438.USD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2468256478","title":"礼来中国副总裁离职，业务架构调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2468256478","media":"药渡","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468256478?lang=zh_cn&edition=full","pubTime":"2024-09-19 07:31","pubTimestamp":1726702287,"startTime":"0","endTime":"0","summary":"据“罗湿兄”消息，礼来中国跨生化事业部副总裁傅祁越即将离职，她的最后工作日为2024年9月30日。傅祁越于2015年7月加入礼来中国，曾担任糖尿病基层事业部总监、糖尿病南中国全国业务总监、糖尿病联盟事业部负责人，以及最近的跨生化事业部副总裁。2024上半年，礼来全球收入200.71亿美元，同比增长31%；净利润52.10亿美元，同比增长74%。礼来还在今年宣布了多次扩产计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919073926956e1881&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919073926956e1881&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0882574055.USD","LU0456855351.SGD","LU1069344957.HKD","BK4533","IE00BK4W5L77.USD","BK4588","LU0094547139.USD","IE00BK4W5M84.HKD","LU0466842654.USD","LU0058720904.USD","LU0471298777.SGD","LU0820561909.HKD","IE0009355771.USD","LU0256863902.USD","LU0256863811.USD","BK4007","BK4581","LU1280957306.USD","LU0320765059.SGD","LU0006306889.USD","LU1061106388.HKD","LU1267930730.SGD","LU1057294990.SGD","LU0882574139.USD","LU0061475181.USD","LU0106261372.USD","LU0238689110.USD","LU1551013342.USD","PFE","LU0417517546.SGD","BK4585","LU0289739699.SGD","LU0823416689.USD","BK4516","LU0114720955.EUR","LLY","IE00BJJMRZ35.SGD","BK4534","LU0097036916.USD","LU0640476718.USD","LU1023059063.AUD","LU0689472784.USD","LU0708995401.HKD","LU1064131342.USD","LU0672654240.SGD","IE00B4R5TH58.HKD","IE0004445239.USD","LU0079474960.USD","IE0002141913.USD","LU0109391861.USD","LU0096364046.USD"],"gpt_icon":1},{"id":"2468332604","title":"医疗行业研究：康方生物重磅数据公布，三季报重点关注药品板块和个股反转","url":"https://stock-news.laohu8.com/highlight/detail?id=2468332604","media":"国金证券","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468332604?lang=zh_cn&edition=full","pubTime":"2024-09-17 18:08","pubTimestamp":1726567685,"startTime":"0","endTime":"0","summary":"行业投资逻辑整体来看，医药依然维持偏弱走势，自2024年初以来生物医药行业下跌19%，位列所有31个申万1级行业的第23位，同期沪深300指数上涨5.6个百分点。同时截至9月1日，已有19个省份及生产建设兵团将辅助生殖技术纳入医保报销范围，纳入医保后，患者支付压力降低，存量及新增需求快速释放。同时，考虑去年同期医疗服务、消费医疗、上游供应链等板块整体基数较低，建议关注这些领域个股业绩增速反弹机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409171808139f027e4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409171808139f027e4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","BK1574","BK1161","LLY","LU0348784397.USD","09926","IE00BPRC5H50.USD","LU0417516571.SGD","LU1720050803.USD","LU2488822045.USD","NVDA","LU0348783233.USD","LU1794554557.SGD","IE00B5MMRT66.SGD"],"gpt_icon":1},{"id":"1122192791","title":"美联储降息赢家是谁？这10只股票在美国经济不衰退情况下历史表现最好","url":"https://stock-news.laohu8.com/highlight/detail?id=1122192791","media":"老虎资讯综合","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122192791?lang=zh_cn&edition=full","pubTime":"2024-09-17 10:26","pubTimestamp":1726539999,"startTime":"0","endTime":"0","summary":"伴随投资者为本周的美联储会议做准备，CNBC Pro 发现，在没有经济衰退环境的情况下降息时，历史上表现良好的股票。许多人现在预计美联储将实现备受期待的“软着陆”，即在不引发经济衰退的情况下抑制通胀。如果包括经济衰退的情况，这一增长下滑至略高于 11%。鉴于这一背景，CNBC Pro筛选出了在美联储降息但美国经济未陷入衰退的时期表现出色的股票。这家零售商是2024年道指表现最好的公司，涨幅高达53%。","market":"us","thumbnail":"https://static.tigerbbs.com/68ab55b396d2dcbb09b0c2d9d4f9ce61","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/68ab55b396d2dcbb09b0c2d9d4f9ce61"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美联储降息赢家是谁？这10只股票在美国经济不衰退情况下历史表现最好","news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBWI","PAYX","LLY","CHD","HRL","NKE","WMT","AMGN","TSN","UNH"],"gpt_icon":1},{"id":"1129282521","title":"礼来公司的翻身奇迹","url":"https://stock-news.laohu8.com/highlight/detail?id=1129282521","media":"财富FORTUNE","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129282521?lang=zh_cn&edition=full","pubTime":"2024-09-16 07:31","pubTimestamp":1726443077,"startTime":"0","endTime":"0","summary":"但最近一段时期，礼来公司却有了很多值得庆祝的事情。礼来公司目前在全球最有价值的公司的排行榜中名列第9位。2023年，礼来公司的销售额创下历史新高，达到341.241亿美元，比上年增长约20%。今年的早些时候，礼来公司仍然处于实验阶段的一种基因疗法还成功治愈了一名耳聋儿童。今年夏天，礼来公司还当上了美国队的奥运赞助商。然而，替尔泊肽受欢迎的程度，甚至超过了礼来公司最疯狂的预测。此时的礼来公司已经多年没有推出新药了。","market":"us","thumbnail":"https://static.tigerbbs.com/c8781df6810484711a3f13f4ff7b6283","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c8781df6810484711a3f13f4ff7b6283"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://mp.weixin.qq.com/s/BJKov7QGY6i4n7S1krsSug","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"礼来公司的翻身奇迹","news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1651116200640","symbols":["LU0823416689.USD","LU0198837287.USD","LU0672654240.SGD","BK4581","IE0002141913.USD","LU0256863811.USD","IE00BJJMRZ35.SGD","BK4516","LU0061475181.USD","LU0006306889.USD","LU0708995401.HKD","LU0820561818.USD","LU0882574139.USD","IE00BFTCPJ56.SGD","LU1069344957.HKD","IE00B4R5TH58.HKD","BK4588","LU0320765059.SGD","LLY","LU0058720904.USD"],"gpt_icon":1},{"id":"2467748022","title":"礼来(LLY.US)重磅新药“替尔泊肽”新适应症在华申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2467748022","media":"智通财经网","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467748022?lang=zh_cn&edition=full","pubTime":"2024-09-15 09:59","pubTimestamp":1726365580,"startTime":"0","endTime":"0","summary":"中国国家药监局药品审评中心(CDE)网站最新公示，礼来(LLY.US)重磅药物GIP/GLP-1受体双重激动剂替尔泊肽注射液新适应症上市申请获得受理，具体适应症尚未披露。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20240915/20240915095209_74099.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240915/20240915095209_74099.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1183432.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"礼来(LLY.US)重磅新药“替尔泊肽”新适应症在华申报上市","news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4533","LU0106261372.USD","GB00BDT5M118.USD","IE00BK4W5L77.USD","LU0820561909.HKD","LU0096364046.USD","LU1057294990.SGD","LU1267930730.SGD","LU0708995401.HKD","IE0002141913.USD","LU0198837287.USD","IE0009355771.USD","LU0943347566.SGD","LU0882574139.USD","LU0417517546.SGD","BK4534","LU0061475181.USD","LU0354030438.USD","LU0820561818.USD","LU0354030511.USD","LU1069344957.HKD","BK4516","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0097036916.USD","LU0689472784.USD","LU0109391861.USD","LU1551013342.USD","LU1280957306.USD","LU1064131342.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","IE00BK4W5M84.HKD","BK4588","LU0882574055.USD","LU0256863902.USD","LLY","LU0466842654.USD","LU0385154629.USD","IE00B4R5TH58.HKD","LU0006306889.USD","IE0004445239.USD","LU0823416689.USD","BK4007","LU0320765059.SGD","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU1061106388.HKD","LU0471298777.SGD"],"gpt_icon":0},{"id":"2467606398","title":"礼来计划投资10亿美元扩建爱尔兰生产基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2467606398","media":"格隆汇","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467606398?lang=zh_cn&edition=full","pubTime":"2024-09-14 14:01","pubTimestamp":1726293700,"startTime":"0","endTime":"0","summary":"格隆汇9月14日｜美国制药巨头礼来公司宣布计划投资10亿美元扩建其位于爱尔兰利默里克的生产基地，使该公司在利默里克地区的投资总额达到20亿美元。计划中的扩建将增加生物活性成分的产量，包括最近获批的用于治疗早期症状性阿尔茨海默病的药物。礼来预计将于2026年开始生产这些药物成分。此举将为利默里克创造150个就业岗位，使该生产基地的员工总数达到450人，生产基地提供的职位包括工程师、科学家、质量保证专业人员和操作人员。该投资需获得规划批准，目前礼来公司正准备向利默里克市和郡议会提交规划申请。礼来公司还宣布斥资8亿美元扩建其位于科克郡金塞尔的工厂，该工厂去年开始生产治疗糖尿病和肥胖症的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240914140210956498b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240914140210956498b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0385154629.USD","LU0943347566.SGD","LU0106261372.USD","LU0466842654.USD","LU0640476718.USD","LU0820561909.HKD","LU1064131342.USD","LU1069344957.HKD","LU1267930730.SGD","LU0198837287.USD","LU0256863811.USD","LU1551013342.USD","LU0096364046.USD","IE0004445239.USD","IE00BJJMRZ35.SGD","BK4581","LU0122379950.USD","LU0882574139.USD","LU0456855351.SGD","BK4588","LU0238689110.USD","IE0009355771.USD","LU0354030511.USD","BK4516","LU0079474960.USD","LU0114720955.EUR","IE0002141913.USD","LU1061106388.HKD","LU0097036916.USD","LLY","LU0471298694.HKD","LU0672654240.SGD","LU0820561818.USD","LU0354030438.USD","LU0823416689.USD","LU0471298777.SGD","LU1035775433.USD","LU0320765059.SGD","LU0417517546.SGD","BK4585","GB00BDT5M118.USD","LU0256863902.USD","LU0882574055.USD","BK4007","IE00B2B36J28.USD","IE00BJLML261.HKD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0689472784.USD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2467700863","title":"礼来下跌1.21%，报923.711美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2467700863","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467700863?lang=zh_cn&edition=full","pubTime":"2024-09-14 02:38","pubTimestamp":1726252688,"startTime":"0","endTime":"0","summary":"9月14日，礼来(LLY)盘中下跌1.21%，截至02:38，报923.711美元/股，成交10.91亿美元。财务数据显示，截至2024年06月30日，礼来收入总额200.71亿美元，同比增长31.42%；归母净利润52.1亿美元，同比增长67.62%。大事提醒：9月9日，礼来获Cantor Fitzgerald重申评级Overweight，目标价885美元。11月7日，礼来将披露2024财年三季报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/09/14023843272570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0061475181.USD","LU1035775433.USD","LU0882574139.USD","IE00B1BXHZ80.USD","BK4585","LU1061106388.HKD","LU0820561909.HKD","LU0882574055.USD","BK4533","IE00BK4W5L77.USD","LU0058720904.USD","LU0354030511.USD","GB00BDT5M118.USD","LU0466842654.USD","IE00BJT1NW94.SGD","LU0943347566.SGD","BK4534","BK4588","LU0109391861.USD","LU0471298694.HKD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU0096364046.USD","LU0097036916.USD","LU0385154629.USD","LU1280957306.USD","LU1057294990.SGD","LU0708995401.HKD","LU0820561818.USD","LU1551013342.USD","LU0114720955.EUR","LU0122379950.USD","LU0289739699.SGD","LU0354030438.USD","IE00BK4W5M84.HKD","LU0672654240.SGD","IE0002141913.USD","LLY","LU0006306889.USD","LU0094547139.USD","BK4007","IE0004445239.USD","LU0256863811.USD","IE0009355771.USD","LU0689472784.USD","LU1069344957.HKD","LU0079474960.USD","IE00BFTCPJ56.SGD","IE00BJLML261.HKD","BK4516"],"gpt_icon":1},{"id":"2467277583","title":"看好“减肥神药”前景 花旗重新覆盖礼来(LLY.US) 予以“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2467277583","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467277583?lang=zh_cn&edition=full","pubTime":"2024-09-13 21:35","pubTimestamp":1726234500,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在评级暂停一段时间后，花旗恢复了对礼来评级。该行给予其“买入”评级，目标价1060美元，理由是看好该公司的GLP-1产品线销售额前景，其中包括其畅销的有着“减肥神药”称号畅销减肥药物Zepbound，该药物的核心成分为替尔泊肽。分析师Peter Verdult的看涨观点基于对替尔泊肽的预测上调，替尔泊肽分别以Mounjaro和Zepbound命名用于治疗糖尿病和肥胖症。该分析师根据该药物最新的销售报告以及处方趋势和指导得出了结论。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1183345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LLY"],"gpt_icon":1},{"id":"2467725112","title":"礼来四赴服贸会 赋能中国医药创新高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2467725112","media":"21世纪经济报道","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467725112?lang=zh_cn&edition=full","pubTime":"2024-09-13 19:19","pubTimestamp":1726226393,"startTime":"0","endTime":"0","summary":"2024年中国国际服务贸易交易会（以下称“服贸会”）于9月12日在北京正式开幕，这是礼来第四年参加服贸会，围绕本届大会“全球服务，互惠共享”主题，礼来重点展示了在糖尿病、肥胖及阿尔茨海默病领域的最新创新成果，并与本土临床研究机构达成合作，共同推动全球同步研发，加速全球创新药惠及中国患者，并携手助力中国创新走向世界。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202409133183186972.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202409133183186972.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0471298694.HKD","LU1069344957.HKD","LU0122379950.USD","LU0354030438.USD","LU0006306889.USD","LU1057294990.SGD","GB00BDT5M118.USD","IE0002141913.USD","BK4581","LU0689472784.USD","LU0882574139.USD","LU0079474960.USD","LU1551013342.USD","IE00B4R5TH58.HKD","LU0385154629.USD","LU0882574055.USD","IE00BJT1NW94.SGD","LU0198837287.USD","LU0823416689.USD","LU0109391861.USD","LU1064131342.USD","LU0061475181.USD","LU0708995401.HKD","LU0094547139.USD","IE00BJJMRZ35.SGD","BK4585","LU0058720904.USD","IE0004445239.USD","BK4516","LU1280957306.USD","LLY","IE00BFTCPJ56.SGD","LU0466842654.USD","LU0256863811.USD","LU0354030511.USD","BK4588","IE00B2B36J28.USD","LU0114720955.EUR","BK4007","LU1061106388.HKD","LU1035775433.USD","IE0009355771.USD","LU0096364046.USD","LU0097036916.USD","LU0640476718.USD","LU0820561909.HKD","IE00BJLML261.HKD","LU0943347566.SGD","IE00B1BXHZ80.USD","LU0820561818.USD"],"gpt_icon":1},{"id":"2467714846","title":"美国研究综述-星座能源公司、礼来公司、塔伦能源公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2467714846","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467714846?lang=zh_cn&edition=full","pubTime":"2024-09-13 15:51","pubTimestamp":1726213914,"startTime":"0","endTime":"0","summary":"    路透9月13日 - 周五，华尔街证券分析师修改了对几家美国上市公司的评级和目标价，其中包括星座能源公司、礼来公司和泰伦能源公司。* Fulcrum Therapeutics Inc   ：加拿大皇家银行将目标价从15美元下调至4美元 * Fulcrum Therapeutics Inc   ：加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RH","MODV","BK4105","FULC","NRG","VRDN","KIDS","ZBH","TLN","HAL","JNJ","IE00BD4GTT62.SGD","BK4592","LLY","ORKA","PLAY","TTD","LU1267930813.SGD","VST","ALK","LU0417517546.SGD","BK4216","LU2298322129.HKD","KR","LU1244550577.SGD","USB","DOW","BK4212","IE00BMG7P587.USD","WDC","IBEX","CPB","LU0965509101.SGD","FERG","LU0234572021.USD","LU0130102774.USD","LU1165135440.EUR","IE00BLSP4239.USD","EW","LH","BK4581","CEG","PEG","AVTR","IE00BLSP4452.SGD","GEV","SHLS"],"gpt_icon":1},{"id":"2467766510","title":"18亿美元！礼来建厂、扩大GLP-1产量","url":"https://stock-news.laohu8.com/highlight/detail?id=2467766510","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467766510?lang=zh_cn&edition=full","pubTime":"2024-09-13 09:37","pubTimestamp":1726191435,"startTime":"0","endTime":"0","summary":"9月12日，礼来表示，该公司已经完成了耗资8亿美元的Kinsale工厂扩建工程，以增加其肥胖和糖尿病药物Mounjaro和Zepbound的产量。施工需获得规划批准，礼来计划很快提交申请。2022年1月，礼来投资4.46亿美元扩大原料药和单克隆抗体的生产。礼来和竞争对手诺和诺德一直在竞相促进各自GLP-1的生产。2022年，辉瑞表示将向都柏林工厂投入近10亿美元。阿斯利康还在 2021 年预算了 3.6 亿美元来建造其第一个爱尔兰工厂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913095702956195aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913095702956195aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0385154629.USD","LU0943347566.SGD","IE00BK4W5M84.HKD","LU0106261372.USD","LU0820561909.HKD","LU1551013342.USD","LU0256863811.USD","BK4590","LU0096364046.USD","IE0004445239.USD","IE00BJJMRZ35.SGD","BK4581","LU0122379950.USD","IE00BK4W5L77.USD","BK4588","IE0009355771.USD","LU0354030511.USD","BK4516","LU0079474960.USD","LU0114720955.EUR","IE0002141913.USD","LU1061106388.HKD","BK4144","LU0061475181.USD","LU0097036916.USD","LU0708995401.HKD","LU1280957306.USD","LLY","LU0471298694.HKD","LU0094547139.USD","LU0672654240.SGD","LU0006306889.USD","LU0354030438.USD","LU1023059063.AUD","LU1035775433.USD","LU1057294990.SGD","LU0320765059.SGD","LU0417517546.SGD","BK4585","GB00BDT5M118.USD","LU0289739699.SGD","GLP","LU0109391861.USD","LU0882574055.USD","BK4007","IE00B1BXHZ80.USD","IE00BJLML261.HKD","IE00BJT1NW94.SGD","LU0058720904.USD","LU0238689110.USD"],"gpt_icon":1},{"id":"2466749206","title":"礼来上涨1.35%，报933.33美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2466749206","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466749206?lang=zh_cn&edition=full","pubTime":"2024-09-12 22:13","pubTimestamp":1726150439,"startTime":"0","endTime":"0","summary":"9月12日，礼来(LLY)盘中上涨1.35%，截至22:13，报933.33美元/股，成交5.0亿美元。财务数据显示，截至2024年06月30日，礼来收入总额200.71亿美元，同比增长31.42%；归母净利润52.1亿美元，同比增长67.62%。大事提醒：9月9日，礼来获Cantor Fitzgerald重申评级Overweight，目标价885美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/09/12221343226410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0823416689.USD","LU0354030438.USD","IE00B1BXHZ80.USD","BK4581","LU0471298694.HKD","LU1280957306.USD","LU0097036916.USD","LU0094547139.USD","BK4007","LU0114720955.EUR","IE0002141913.USD","LU0385154629.USD","LU0256863811.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU0096364046.USD","LU0354030511.USD","GB00BDT5M118.USD","LU1057294990.SGD","LU0820561909.HKD","LU1551013342.USD","LU1061106388.HKD","BK4516","LU0122379950.USD","LU0061475181.USD","IE00BJLML261.HKD","LU0689472784.USD","IE00BK4W5L77.USD","LU0109391861.USD","LU0006306889.USD","LU1035775433.USD","IE0009355771.USD","LU0708995401.HKD","IE00BK4W5M84.HKD","IE00BJT1NW94.SGD","BK4533","LU0466842654.USD","LU0820561818.USD","LU0882574139.USD","IE00BFTCPJ56.SGD","LU1069344957.HKD","IE0004445239.USD","LU0289739699.SGD","BK4588","LU0943347566.SGD","LLY","BK4585","LU0058720904.USD","LU0079474960.USD","LU0882574055.USD"],"gpt_icon":1},{"id":"2466885203","title":"斥资18亿美元！礼来扩建爱尔兰工厂，加大减肥药生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2466885203","media":"华尔街见闻","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466885203?lang=zh_cn&edition=full","pubTime":"2024-09-12 21:39","pubTimestamp":1726148365,"startTime":"0","endTime":"0","summary":"礼来的减肥药被认为是历史上最畅销的药物之一。本次，礼来计划斥资10亿美元扩建位于爱尔兰利默里克的现有工厂，还将斥资8亿美元在爱尔兰科克郡金赛尔镇的工厂建造新设施，努力满足其明星药物Mounjaro和Zepbound的市场需求。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/8cad0f48-6a49-4781-b8b9-a6be3ce797bb.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/8cad0f48-6a49-4781-b8b9-a6be3ce797bb.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3727852","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3727852","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"斥资18亿美元！礼来扩建爱尔兰工厂，加大减肥药生产","news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["BK4533","IE00BFTCPJ56.SGD","IE0002141913.USD","IE0004445239.USD","LU0354030511.USD","LU1023059063.AUD","LU0689472784.USD","LU0122379950.USD","LU0256863811.USD","IE0009355771.USD","LU0943347566.SGD","IE00BJLML261.HKD","BK4516","BK4585","BK4534","LU0471298694.HKD","IE00BJT1NW94.SGD","LU1035775433.USD","LU0708995401.HKD","LU0820561818.USD","LU0882574139.USD","LU1280957306.USD","LU1069344957.HKD","LU0114720955.EUR","LLY","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0820561909.HKD","IE00BK4W5L77.USD","IE00BK4W5M84.HKD","LU0061475181.USD","LU0385154629.USD","BK4588","LU0079474960.USD","LU0466842654.USD","BK4007","LU0882574055.USD","LU1061106388.HKD","LU0823416689.USD","LU0094547139.USD","GB00BDT5M118.USD","IE00B1BXHZ80.USD","LU1057294990.SGD","LU0109391861.USD","LU0097036916.USD","LU0289739699.SGD","LU0006306889.USD","LU1551013342.USD","LU0354030438.USD","LU0096364046.USD"],"gpt_icon":1},{"id":"2466922605","title":"礼来投资 18 亿美元在爱尔兰建厂，以扩大阿尔茨海默氏症和肥胖症药物的生产规模","url":"https://stock-news.laohu8.com/highlight/detail?id=2466922605","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466922605?lang=zh_cn&edition=full","pubTime":"2024-09-12 17:30","pubTimestamp":1726133409,"startTime":"0","endTime":"0","summary":"    路透9月12日 -    礼来   制药公司周四表示，将投资18亿美元在爱尔兰的两个生产基地，以提高其广受欢迎的肥胖症药物和一种新批准的阿尔茨海默氏症治疗药物的产量。其余投资将用于扩建这家制药商在爱尔兰 利默里克的工厂， 该工厂将重点生产某些药物 的活性生物成分，包括 治疗阿尔茨海默氏症的药物 。礼来治疗阿尔茨海默氏症的药物已于今年 7 月获得美国批准， 目前正在  接受欧洲和英国卫生监管机构的审查。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765059.SGD","LU0094547139.USD","LU0122379950.USD","LU1267930730.SGD","IE00BFTCPJ56.SGD","IE00B1BXHZ80.USD","LU1064131342.USD","LU0466842654.USD","CTLT","LU0471298777.SGD","LU1023059063.AUD","BK4533","LU0198837287.USD","LU1069344957.HKD","LU0820561818.USD","LU1057294990.SGD","IE00BK4W5L77.USD","LU0058720904.USD","LU0096364046.USD","BK4585","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0385154629.USD","LU1280957306.USD","BK4588","LU0672654240.SGD","LU0006306889.USD","LU0820561909.HKD","LU0823416689.USD","LLY","LU0456855351.SGD","LU0882574139.USD","IE00BK4W5M84.HKD","LU0106261372.USD","LU0640476718.USD","LU0114720955.EUR","IE00B2B36J28.USD","LU0238689110.USD","LU1035775433.USD","LU0417517546.SGD","IE0009355771.USD","LU0097036916.USD","LU0109391861.USD","LU0289739699.SGD","BK4534","LU0689472784.USD","LU0708995401.HKD","BK4581","LU0256863902.USD","LU0061475181.USD"],"gpt_icon":1},{"id":"2466238470","title":"晨星公司料诺和诺德(NVO和礼来(LLY)仍主导GLP-1类减肥药物市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2466238470","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466238470?lang=zh_cn&edition=full","pubTime":"2024-09-11 17:08","pubTimestamp":1726045696,"startTime":"0","endTime":"0","summary":"晨星公司补充称，这些新药可能会从诺和诺德和礼来手中夺走部分市场份额，但这两家减肥药巨头仍将保留近70%的市场份额。不过，该公司也认为，诺和诺德与礼来的股票“估值过高”。此外，更多的竞争也会给GLP-1类减肥药物价格带来额外的压力。晨星公司预计，到2027年，随着竞争对手努力进入医疗保险覆盖范围，新进入者将导致GLP-1类减肥药物价格年跌幅加速至10%-15%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"279785","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHHBY","LU0061475181.USD","AMGN","IE00BLSP4452.SGD","IE00BK4W5M84.HKD","PFE","LU0321505868.SGD","LU1983299246.USD","AZN","IE00BLSP4239.USD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","BK4534","LU0321505439.SGD","SG9999001176.SGD","LU0320765992.SGD","03165","SG9999001176.USD","IE00BK4W5L77.USD","IE00BJT1NW94.SGD","BK4533","LU1571399168.USD","LU0122379950.USD","LU0708995401.HKD","NVO","LU0471298694.HKD","BK4532","IE00BBT3K403.USD","LU0109391861.USD","LU1057294990.SGD","LU0225771236.USD","LU1280957306.USD","LU2236285917.USD","SG9999013999.USD","LU1093756168.USD","LU1035775433.USD","GLP","LU0006306889.USD","LLY","SG9999001440.SGD","GPCR","LU0234572021.USD","LU1023059063.AUD","LU0094547139.USD","IE00B1BXHZ80.USD","SGXZ57979304.SGD","IE0002270589.USD","BK4007","LU0868494617.USD"],"gpt_icon":1},{"id":"2466203004","title":"晨星公司：2029年或有多达16种新的GLP-1类减肥药物上市 诺和诺德和礼来仍主导市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2466203004","media":"格隆汇","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466203004?lang=zh_cn&edition=full","pubTime":"2024-09-11 14:26","pubTimestamp":1726035988,"startTime":"0","endTime":"0","summary":"格隆汇9月11日｜根据晨星公司和Pitchbook的一份新报告，到2029年，可能会有多达16种新的GLP-1类减肥药物上市，最终将占据到2031年潜在的2000亿美元市场的近三分之一。晨星公司预计，到2031年，该市场仍将由诺和诺德和礼来主导。这些新药可能会从诺和诺德和礼来手中夺走部分市场份额，但这两家减肥药巨头仍将保留近70%的市场份额。此外，晨星公司预计，到2027年，随着竞争对手努力进入医疗保险覆盖范围，新进入者将导致GLP-1类减肥药物价格年跌幅加速至10%-15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409111426409ef40643&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409111426409ef40643&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0466842654.USD","LLY","LU1064131342.USD","LU1069344957.HKD","LU0823416689.USD","NVO","LU0943347566.SGD","LU0385154629.USD","BK4516","IE00BK4W5L77.USD","LU0238689110.USD","LU2065731478.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","LU0820561818.USD","LU0882574139.USD","LU0471298777.SGD","LU0096364046.USD","LU0198837287.USD","IE00B2B36J28.USD","LU0289739699.SGD","LU0320765059.SGD","PFE","IE00BK4W5M84.HKD","LU0672654240.SGD","LU1057294990.SGD","BK4532","BK4590","BK4585","LU0456855351.SGD","IE0009355771.USD","LU0097036916.USD","BK4007","BK4112","LU0106261372.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE00BKVL7J92.USD","GLP","LU0417517546.SGD","LU0114720955.EUR","LU0640476718.USD","LU0094547139.USD","LU0820561909.HKD","LU0256863902.USD","MORN","BK4533","BK4534","LU1267930730.SGD"],"gpt_icon":1},{"id":"2466441403","title":"16款新GLP-1类减肥药或于2029年上市 但诺和诺德(NVO.US)、礼来(LLY.US)仍将主导市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2466441403","media":"智通财经网","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466441403?lang=zh_cn&edition=full","pubTime":"2024-09-11 10:44","pubTimestamp":1726022699,"startTime":"0","endTime":"0","summary":"根据晨星公司和Pitchbook的一份新报告，到2029年，可能会有多达16种新的GLP-1类减肥药物上市，最终将占据到2031年潜在的2000亿美元市场的近三分之一。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20240911/20240911095514_50271.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240911/20240911095514_50271.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1181757.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0820561909.HKD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","NVO","GLP","LU0106261372.USD","IE00BK4W5L77.USD","LU0154236417.USD","LU1267930730.SGD","BK4581","BK4532","LU0471298777.SGD","LU0061475181.USD","LU0109391861.USD","LU0256863902.USD","BK4007","LU0466842654.USD","LU0417517546.SGD","LU1064131342.USD","BK4533","IE0009355771.USD","LLY","LU0640476718.USD","IE00BZ1G4Q59.USD","LU0689472784.USD","LU0006306889.USD","PFE","BK4534","LU0094547139.USD","BK4144","IE00BK4W5M84.HKD","BK4590","IE00BKVL7J92.USD","LU0672654240.SGD","LU0385154629.USD","LU0238689110.USD","LU0882574139.USD","LU0289739699.SGD","LU1093756168.USD","LU0320765059.SGD","LU0096364046.USD","LU0820561818.USD","BK4588","LU1069344957.HKD","IE00B2B36J28.USD","LU0198837287.USD","LU0456855351.SGD","LU1057294990.SGD","LU0823416689.USD","LU1023059063.AUD","LU0097036916.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.lilly.com","stockEarnings":[{"period":"1week","weight":-0.0173},{"period":"1month","weight":-0.0183},{"period":"3month","weight":0.0214},{"period":"6month","weight":0.1744},{"period":"1year","weight":0.574},{"period":"ytd","weight":0.5525}],"compareEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0.0032},{"period":"3month","weight":0.0263},{"period":"6month","weight":0.0771},{"period":"1year","weight":0.2681},{"period":"ytd","weight":0.1811}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"礼来公司于1901年在印第安纳州注册成立，其前身是1876年由伊利·礼来上校在印第安纳州印第安纳波利斯创立的药品生产企业。公司发现，开发，制造和销售重要医药产品。公司的宗旨是将“关爱”与“发现”结合起来，为世界各地的人们创造更美好的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.011498},{"month":2,"riseRate":0.5,"avgChangeRate":-0.002909},{"month":3,"riseRate":0.613636,"avgChangeRate":0.015389},{"month":4,"riseRate":0.555556,"avgChangeRate":0.018718},{"month":5,"riseRate":0.422222,"avgChangeRate":0.014916},{"month":6,"riseRate":0.6,"avgChangeRate":0.02296},{"month":7,"riseRate":0.555556,"avgChangeRate":-0.000346},{"month":8,"riseRate":0.422222,"avgChangeRate":0.004313},{"month":9,"riseRate":0.444444,"avgChangeRate":0.001859},{"month":10,"riseRate":0.590909,"avgChangeRate":0.014439},{"month":11,"riseRate":0.75,"avgChangeRate":0.027866},{"month":12,"riseRate":0.590909,"avgChangeRate":0.031834}],"exchange":"NYSE","name":"礼来","nameEN":"Eli Lilly"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"礼来,LLY,礼来股票,礼来股票老虎,礼来股票老虎国际,礼来行情,礼来股票行情,礼来股价,礼来股市,礼来股票价格,礼来股票交易,礼来股票购买,礼来股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}